Frog Bacteria Erased Cancer Tumors in Mice With One Dose

Scientists in Japan just discovered a bacteria living inside tree frogs that completely wiped out cancer tumors in mice with just one dose.

Researchers at the Japan Advanced Institute of Science and Technology collected 45 bacterial strains from the guts of Japanese tree frogs, newts, and lizards. They were searching for naturally occurring bacteria that might fight cancer in new ways.

One strain stood out from all the rest. Ewingella americana, found in tree frog intestines, eliminated 100% of colorectal tumors in mice after a single injection into the bloodstream.

That result beat standard treatments used today, including chemotherapy and immune checkpoint inhibitors. The bacteria worked so well because it attacked cancer through two different pathways at once.

First, the bacteria multiplied directly inside tumors. Cancer creates low-oxygen zones that most healthy tissue doesn't have, and this bacteria thrives in exactly those conditions. Within 24 hours of treatment, the bacterial population inside tumors grew 3,000 times larger, directly damaging cancer cells.

Second, the bacteria called in reinforcements from the immune system. Its presence attracted T cells, B cells, and neutrophils into the tumors, creating an inflammatory response that helped destroy remaining cancer cells.

The bacteria showed remarkable accuracy. It accumulated almost exclusively inside tumors and avoided healthy organs entirely. Leaky blood vessels around tumors, low oxygen levels, and cancer-specific nutrients all helped guide the bacteria to exactly where it needed to go.

Safety results looked encouraging too. The bacteria cleared from the bloodstream in about 1.2 hours and became undetectable within 24 hours. No bacteria colonized healthy organs like the liver, spleen, lungs, kidneys, or heart.

Mice experienced only mild, temporary inflammation that resolved within 72 hours. Over a 60-day observation period, researchers found no signs of chronic toxicity or long-term side effects.

The team emphasized these results are limited to mice and represent early proof of concept. But they believe the approach could potentially work against other solid tumors, including breast cancer, pancreatic cancer, and melanoma.

The Bright Side

This discovery showcases why protecting biodiversity matters beyond conservation. The bacteria came from common amphibians living in Japan, creatures most people walk past without a second thought.

Researchers are now planning next steps. They want to test whether the bacteria works even better when combined with existing chemotherapy or immunotherapy drugs. They'll also explore different delivery methods, including injecting bacteria directly into tumors.

For patients facing cancers that resist current treatments, this research offers genuine hope that nature might hold answers we haven't discovered yet.